by rdbiomed | Nov 28, 2019 | Company News
Let’s introduce you to a key member of the RD Biomed and Peptest team… Jeanine Fisher. Jeanine joined our company in 2006 and can usually be found in the Peptest laboratories at Castle Hill Hospital in Hull. As a Senior Laboratory Technician – and Project... 
by rdbiomed | Nov 21, 2019 | Company News
Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China. The device detects the presence of pepsin (recognised as a diagnostic biomarker for reflux) in saliva samples. Leading... 
by rdbiomed | Nov 6, 2019 | Company News
The Peptest team headed to the Czech Republic in October to take part in the second annual ‘Peptest Day’ hosted by Imedex. Imedex, our exclusive distributor for the Czech Republic and Slovakia, organised the knowledge-sharing workshop to coincide with the Pneumology... 
by rdbiomed | Sep 9, 2019 | Company News
The Peptest team has headed to China this week to finalise plans for the official launch of our reflux diagnostic device in the world’s most populous country. In an exciting development for Peptest, we’re thrilled to reveal that following years of intensive research,... 
by rdbiomed | Sep 4, 2019 | Company News
We are delighted to introduce our new step-by-step video guide to using Peptest in the comfort of your own home. Peptest is an innovative diagnostic test to help identify reflux non-invasively. We measure the presence of stomach enzyme pepsin in your saliva samples.... 
by rdbiomed | Aug 19, 2019 | Company News
A large-scale, multicentre study that validates the effectiveness of using Peptest to diagnose patients with gastroesophageal reflux in China has been published in the Journal of Digestive Diseases. Pepsin in saliva has been recognised as a diagnostic biomarker in...
Recent Comments